Facing one of the highest Ulcerative Colitis (UC) rates in the world, Australian health officials have taken a number of steps toward creating evidence-based treatment guidelines that can more effectively help patients through this difficult condition.
And yet, says Rebecca Agnew from Shire Australia, a number of issues remain:
“It’s a set of circumstances that can lead to poor outcomes for patients and a growing frustration amongst the medical community in Inflammatory Bowel Disease,” says Pip Paterson, Senior Product Manager at Shire.
Shire Australia worked collaboratively with a Steering Committee of five leading Australian Gastroenterologists to both identify the problems and to help address them. The result of that collaboration was a 45-person multidisciplinary working party that met in Sydney in March 2014 with the objective to try to “improve outcomes for patients with mild-moderate UC by building an interactive forum in which innovation and best practices can be shared, debated, and created.”
The working party was comprised of:
Says Paterson: “Their commitment to helping patients achieve success in choosing the right treatment paths, adhering to proper treatment, living beyond inflammation, and managing the disease over the long term was inspirational.”
The result of the meeting was the creation of three mild-moderate UC Management Tools; two Guides for Primary Care Physicians; and a Patient Management Plan.
It is, in other words, a true win-win.
Having been recently presented at Australia’s premiere Gastroenterology meeting, the Australian Gastroenterology Week, the tools are currently being piloted in clinical practice. Following the pilot, the tools will be launched in May 2014, in partnership between Shire and the Steering Committee members.